EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vitamin D Status and Psoriatic Arthritis: Association with the Risk for Sacroiliitis and Influence on the Retention Rate of Methotrexate Monotherapy and First Biological Drug Survival—A Retrospective Study

Cinzia Rotondo iD, Francesco Paolo Cantatore iD, Daniela Cici iD, Francesca Erroi iD, Stefania Sciacca iD, Valeria Rella iD, Addolorata Corrado

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24065368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Cinzia Rotondo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Unit, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy. Hauptthemen laut MEDLINE: Arthritis, Psoriatic, Sacroiliitis, Vitamin D Deficiency, Antirheumatic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A growing body of evidence on the importance of vitamin D in immune modulation has increased the interest in its possible impact on the course of rheumatological diseases. The scope of our study is to assess if the presence of different statuses of vitamin D could interfere in the clinical subsets, in methotrexate monotherapy discontinuation, and biological drug (b-DMARDs) survival in psoriatic arthritis patients (PsA). We conducted a retrospective study on PsA patients and split them into three groups based on their vitamin D status: the group with 25(OH)D ≤ 20 ng/mL, the group with levels of 25(OH)D between 20 and 30 ng/mL, and the group with serum levels of 25(OH)D ≥ 30 ng/mL. All patients were required to fulfill the CASPAR criteria for psoriatic arthritis and to have the evaluation of vitamin D serum levels at baseline visit and at clinical follow-up visits. The exclusion criteria were ages less than 18 years old, the presence of HLA B27, and satisfaction of rheumatoid arthritis classification criteria (during the study time). Statistical significance was set at p ≤ 0.05. Furthermore, 570 patients with PsA were screened and 233 were recruited. A level of 25(OH)D ≤ 20 ng/mL was present in 39% of patients; levels of 25(OH)D between 20 and 30 ng/mL presented in 25% of patients; 65% of patients with sacroiliitis presented 25 (OH)D ≤ 20 ng/mL. Methotrexate monotherapy discontinuation for failure was higher in the group with 25 (OH)D ≤ 20 ng/mL (survival time: 92 ± 10.3 weeks vs. 141.9 ± 24.1 weeks vs. 160.1 ± 23.6 weeks; p = 0.02) with higher discontinuation risk (HR = 2.168, 95% CI 1.334, 3.522; p = 0.002) than those with 25(OH)D between 20 and 30 ng/mL and those with 25(OH)D ≥ 30 ng/mL. Significantly shorter survival of first b-DMARDs was assessed in the group with 25 (OH)D ≤ 20 ng/mL versus the other groups (133.6 ± 11 weeks vs. 204.8 ± 35.8 weeks vs. 298.9 ± 35.4; p = 0.028) (discontinuation risk 2.129, 95% CI 1.186, 3.821; p = 0.011). This study highlights significant differences in clinical presentation, in particular sacroiliac involvement and on drug survival (methotrexate and b-DMARDs) in PsA patients with vitamin D deficiency. Further prospective studies, including a larger sample of patients, are needed to validate these data and to assess if the supplementation of vitamin D could improve the b-DMARDs response in PsA patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, PsoriaticSacroiliitisVitamin D DeficiencyAntirheumatic AgentsHumansAdolescentVitamin DRetrospective StudiesMethotrexateProspective StudiesVitamins

Stichwörter der Autor:innen

DMARDsbiological drugsmethotrexatepsoriatic arthritisvitamin D deficiency or insufficiency

Substanzen

Vitamin DMethotrexateVitaminsAntirheumatic Agents

Autor:innen und Institutionen

  • Rheumatology Unit, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.

ORCID-Profile: Cinzia Rotondo, Francesco Paolo Cantatore, Daniela Cici, Francesca Erroi, Stefania Sciacca, Valeria Rella

Zitieren

APA

Rotondo, C., Cantatore, F. P., Cici, D., Erroi, F., Sciacca, S., Rella, V., & Corrado, A. (2023). Vitamin D Status and Psoriatic Arthritis: Association with the Risk for Sacroiliitis and Influence on the Retention Rate of Methotrexate Monotherapy and First Biological Drug Survival—A Retrospective Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065368

Vancouver

Rotondo C, Cantatore FP, Cici D, Erroi F, Sciacca S, Rella V, et al. Vitamin D Status and Psoriatic Arthritis: Association with the Risk for Sacroiliitis and Influence on the Retention Rate of Methotrexate Monotherapy and First Biological Drug Survival—A Retrospective Study. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065368

BibTeX
@article{Rotondo2023,
  author = {Rotondo, Cinzia and Cantatore, Francesco Paolo and Cici, Daniela and Erroi, Francesca and Sciacca, Stefania and Rella, Valeria and Corrado, Addolorata},
  title = {Vitamin D Status and Psoriatic Arthritis: Association with the Risk for Sacroiliitis and Influence on the Retention Rate of Methotrexate Monotherapy and First Biological Drug Survival—A Retrospective Study},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24065368}
}
Kostenlos starten →